PR Newswire Asia's news > Health Care/Hospital

 < Previous page   |   Title only   |   Print    Next page > 
     
Suvoda's latest platform release creates a global experience across study data, patient engagement, scheduling, payments, and clinical trial operations
CONSHOHOCKEN, Pa. , Sept. 30, 2026 /PRNewswire/ -- Suvoda , a global clinical trial technology company, today announced a new release of important advancements since unifying the market-leading ...
2026-09-30T    Computer Software   Computer/Electronics   Health Care/Hospital   Mobile Entertainment 
Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month
Piramal and NP2 are set to complete the drug development phase of the generic cancer drug cyclophosphamide this October. The development and manufacturing activities are being conducted at Piramal's ...
2026-09-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Phrontline Biopharma Doses First Patient in Global Phase I/II Trial of TJ102, an FRα × CDH6 Bispecific Dual-Payload ADC
First clinical program built on Phrontline's DLP1 branched dual-payload linker platform ...
2026-09-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
The 94th CMEF, the World's Leading Medical Device Industry Event, Set to Open in Beijing Oct. 21-24
BEIJING , Sept. 30, 2026 /PRNewswire/ -- The 94th China International Medical Equipment Fair (CMEF) and concurrent events—including ICMD, covering medical device design and manufacturing; CRS, focusing ...
2026-09-30T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Yuyu Pharma Brings Ari's Purrfect to Amazon Accelerate 2026
Korean pharmaceutical company explores Amazon AI and seller tools to grow its U.S. feline-health brand ...
2026-09-30T    Biotechnology   Computer/Electronics   Electronic Commerce   Health Care/Hospital 
Joint Commission International Honors Healthcare Organizations and National Health Authorities with Inaugural Global Patient Safety Awards
OAK BROOK TERRACE, Ill. , Sept. 30, 2026 /PRNewswire/ -- Joint Commission International (JCI) recognized the winners of the inaugural Global Patient Safety Awards today at UNIFY 2026™: Convening for ...
2026-09-30T    Health Care/Hospital   Medical Equipment 
Zhendong Pharmaceutical Announces Publication of Phase IIb Study of Investigational Vaginal Lactobacillus Capsule in the National Medical Journal of China
BEIJING , Sept. 30, 2026 /PRNewswire/ -- Zhendong Pharmaceutical announced that results from a multicenter, randomized, double-blind, placebo-controlled Phase IIb study evaluating its investigational ...
2026-09-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
POMDOCTOR LIMITED Accelerates AI-Enabled Chronic Disease Management and RWD Commercialization
GUANGZHOU, China , Sept. 30, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare ...
2026-09-30T    Health Care/Hospital   Medical Equipment 
Zhongchao Inc. Announces 1-for-2 Share Consolidation
SHANGHAI , Sept. 30, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients ...
2026-09-30T    Banking/Financial Service   Health Care/Hospital   Internet Technology 
Zhendong Pharmaceutical Announces Publication of Phase IIb Study of Investigational Vaginal Lactobacillus Capsule in the National Medical Journal of China
BEIJING , Sept. 30, 2026 /PRNewswire/ -- Zhendong Pharmaceutical announced that results from a multicenter, randomized, double-blind, placebo-controlled Phase IIb study evaluating its investigational ...
2026-09-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.